soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Novo Nordisk reports showing reduced risk with in type 2 diabetes Emily Kronau, PharmD, MBA (@Phar_em_D)
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28








)
















